Dementia with lewy bodies - Clinical features and treatment

被引:24
作者
Campbell, S [1 ]
Stephens, S [1 ]
Ballard, C [1 ]
机构
[1] Newcastle Gen Hosp, Wolfson Res Ctr, Inst Hlth Elderly, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
关键词
D O I
10.2165/00002512-200118060-00002
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Dementia with Lewy bodies (DLB) accounts for 15 to 20% of late-onset dementias. The overlap of cognitive symptoms, neuropsychiatric features, parkinsonism and severe sensitivity to antipsychotic drugs raise a number of key management issues. The neurochemical profile of DLB provides a good theoretical rationale for the potential value of cholinesterase inhibitor therapy, which is supported by clinical evidence from a number of case series and one placebo-controlled double-blind trial. It appears that cholinesterase inhibitor treatment is well tolerated and improves fluctuating confusion, cognition and psychotic symptoms; however, the evidence can still only be considered preliminary and a further double-blind study is imperative. Given the high prevalence of severe sensitivity to antipsychotic drugs in patients with DLB, their role in the treatment of psychiatric symptoms and behavioural problems is uncertain, although a small case report literature indicates that some patients may benefit. On the current balance of evidence, prescription of antipsychotic agents to patients with DLB is not recommended, although further studies focussing on patients with severe and intractable neuropsychiatric symptoms are required. Provisional case series indicate a high degree of motor response to levodopa therapy, although controlled trials are a priority to carefully evaluate the benefits in the context of possible adverse effects, such as the exacerbation of psychosis.
引用
收藏
页码:397 / 407
页数:11
相关论文
共 60 条
[1]  
Aarsland D, 1999, INT J GERIATR PSYCH, V14, P69, DOI 10.1002/(SICI)1099-1166(199901)14:1<69::AID-GPS888>3.0.CO
[2]  
2-C
[3]   Hallucinations and signs of parkinsonism help distinguish patients with dementia and cortical Lewy bodies from patients with Alzheimer's disease at presentation: A clinicopathological study [J].
Ala, TA ;
Yang, KH ;
Sung, JH ;
Frey, WH .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 62 (01) :16-21
[4]   RISPERIDONE FOR PSYCHOTIC AND BEHAVIORAL SYMPTOMS IN LEWY BODY DEMENTIA [J].
ALLEN, RL ;
WALKER, Z ;
DATH, PJ ;
KATONA, CLE .
LANCET, 1995, 346 (8968) :185-185
[5]  
AYRE GA, IN PRESS NEUROLOGY
[6]   Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease [J].
Ballard, C ;
Grace, J ;
McKeith, I ;
Holmes, C .
LANCET, 1998, 351 (9108) :1032-1033
[7]   One year follow-up of parkinsonism in dementia with Lewy bodies [J].
Ballard, C ;
O'Brien, J ;
Swann, A ;
Neill, D ;
Lantos, P ;
Holmes, C ;
Burn, D ;
Ince, P ;
Perry, R ;
McKeith, I .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2000, 11 (04) :219-222
[8]  
Ballard C., 1996, P67, DOI 10.1017/CBO9780511601187.010
[9]   Treating behavioural and psychological signs in Alzheimer's disease - The evidence for current pharmacological treatments is not strong [J].
Ballard, C ;
O'Brien, J .
BRITISH MEDICAL JOURNAL, 1999, 319 (7203) :138-139
[10]   Neuropsychiatric aspects of Alzheimer's disease. [J].
Ballard C. ;
Walker M. .
Current Psychiatry Reports, 1999, 1 (1) :49-60